Israel’s FertilAI Earns EU Clearance for AI Platform Optimizing IVF Timing
Israeli fertility tech firm FertilAI has earned EU clearance for its AI platform, Fertilane, to optimize IVF timing and improve outcomes across the European.
Jerusalem, 16 April, 2026 (TPS-IL) — Israeli fertility tech firm FertilAI has secured CE marking under the European Union’s Medical Device Regulation, allowing its AI-driven clinical decision support tools to be marketed across the EU after meeting safety, health and performance standards.
The Tel Aviv-based company said its Fertilane platform integrates with existing clinic systems and uses data from more than 100,000 cycles to guide decision-making. Its StimAI and OvuPredict algorithms help forecast optimal trigger timing, ovulation and expected oocyte yields, aiming to improve IVF outcomes and streamline clinic workloads.
